IP Group
www.ipgroupplc.com
IP Group was founded in 2001 and is listed on the main market of the LSE. It invests in companies underpinned by IP and scientific innovation, across HealthTech, DeepTech, CleanTech. Investments are sourced via partnerships with universities (including Oxford, Cambridge, Imperial and UCL), research institutions and other networks. The on-balance-sheet portfolio value is>£0.9bn, with >£0.5bn managed for 3rd parties. The portfolio has produced 4 unicorns and realised >£1.1bn.
Positive phase 2 trial for new cystic fibrosis drug
IP Group portfolio company, Enterprise Therapeutics, has announced positive results from its Phase...
Read moreChair Designate is Michael Queen, ex CEO of 3i
Chair appointment: IP Group has appointed Michael Queen (ex‑CEO of 3i) as Chair Designate,...
Read more- Prev
- 1 of 1 pages
Register to be first
Get research on the companies that interest you straight to your inbox
